1. Home
  2. NEXT vs NNNN Comparison

NEXT vs NNNN Comparison

Compare NEXT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$5.19

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$24.60

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
NNNN
Founded
2010
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
NEXT
NNNN
Price
$5.19
$24.60
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
2.8M
88.1K
Earning Date
03-02-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$6,920,153.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$412.64
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$5.18
52 Week High
$12.12
$55.65

Technical Indicators

Market Signals
Indicator
NEXT
NNNN
Relative Strength Index (RSI) 47.54 47.76
Support Level $5.07 $21.09
Resistance Level $5.56 $28.00
Average True Range (ATR) 0.25 6.50
MACD 0.02 0.26
Stochastic Oscillator 48.45 27.83

Price Performance

Historical Comparison
NEXT
NNNN

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: